Home > Compound List > Product Information
4-Fluoroindole_Molecular_structure_CAS_387-43-9)
Click picture or here to close

4-Fluoroindole

Catalog No. 457396 Name Sigma Aldrich
CAS Number 387-43-9 Website http://www.sigmaaldrich.com
M. F. C8H6FN Telephone 1-800-521-8956
M. W. 135.1383432 Fax
Purity 97% Email
Storage Chembase ID: 64412

SYNONYMS

Title
4-氟吲哚
IUPAC name
4-fluoro-1H-indole
IUPAC Traditional name
4-fluoro-1H-indole

DATABASE IDS

PubChem SID 24869313
MDL Number MFCD00055992
CAS Number 387-43-9

PROPERTIES

Empirical Formula (Hill Notation) C8H6FN
Purity 97%
Boiling Point 90 °C/0.4 mmHg(lit.)
Melting Point 30-32 °C(lit.)
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26-36
German water hazard class 3

DETAILS

Description (English)
Packaging
1 g in glass bottle
Application

• Reactant for preparation of tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators1
• Reactant for preparation of antifungal agents2
• Reactant for preparation of Sodium-Dependent Glucose Co-transporter 2 (SGLT2) Inhibitors for the Management of Hyperglycemia in Diabetes3
• Reactant for preparation of Potent Selective Serotonin Reuptake Inhibitors4
• Reactant for preparation of Inhibitors of HIV-1 attachment5
• Reactant for preparation of monoamine reuptake inhibitors6
• Reactant for preparation of histone deacetylase (HDAC) inhibitors7
• Reactant for preparation of inhibitors of proliferation of human breast cancer cells8
Description (简体中文)
包装
1 g in glass bottle
Application

• Reactant for preparation of tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators1
• Reactant for preparation of antifungal agents2
• Reactant for preparation of Sodium-Dependent Glucose Co-transporter 2 (SGLT2) Inhibitors for the Management of Hyperglycemia in Diabetes3
• Reactant for preparation of Potent Selective Serotonin Reuptake Inhibitors4
• Reactant for preparation of Inhibitors of HIV-1 attachment5
• Reactant for preparation of monoamine reuptake inhibitors6
• Reactant for preparation of histone deacetylase (HDAC) inhibitors7
• Reactant for preparation of inhibitors of proliferation of human breast cancer cells8

REFERENCES